Legal & General Group Plc lifted its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 9.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,051,114 shares of the real estate investment trust's stock after buying an additional 580,870 shares during the period. Legal & General Group Plc owned approximately 1.01% of Healthpeak Properties worth $113,382,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its stake in Healthpeak Properties by 41.0% in the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust's stock valued at $540,730,000 after buying an additional 8,212,504 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Healthpeak Properties by 694.6% during the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust's stock worth $153,520,000 after acquiring an additional 7,007,777 shares during the last quarter. Equity Investment Corp grew its stake in shares of Healthpeak Properties by 209.6% during the third quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust's stock worth $102,088,000 after acquiring an additional 3,608,849 shares during the last quarter. Bank of America Corp DE grew its stake in shares of Healthpeak Properties by 28.5% during the third quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust's stock worth $190,292,000 after acquiring an additional 2,206,222 shares during the last quarter. Finally, Russell Investments Group Ltd. grew its stake in shares of Healthpeak Properties by 176.4% during the third quarter. Russell Investments Group Ltd. now owns 3,063,569 shares of the real estate investment trust's stock worth $58,663,000 after acquiring an additional 1,955,273 shares during the last quarter. 93.57% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the business's stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. The trade was a 59.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.23% of the company's stock.
Healthpeak Properties Stock Down 1.9%
Healthpeak Properties stock opened at $19.49 on Friday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The business's 50-day simple moving average is $17.70 and its two-hundred day simple moving average is $17.32. The company has a market cap of $13.44 billion, a PE ratio of 60.90, a PEG ratio of 2.52 and a beta of 1.00. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $20.27.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. The business had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company's quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Equities analysts anticipate that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.
Healthpeak Properties Announces Dividend
The company also recently declared a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be paid a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 6.3%. The ex-dividend date is Monday, June 15th. Healthpeak Properties's payout ratio is presently 381.25%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on the company. Robert W. Baird boosted their price target on Healthpeak Properties from $19.00 to $21.00 and gave the stock an "outperform" rating in a research note on Wednesday, May 13th. Citigroup boosted their price target on Healthpeak Properties from $17.50 to $20.00 and gave the stock a "neutral" rating in a research note on Tuesday, May 12th. UBS Group boosted their price objective on shares of Healthpeak Properties from $17.00 to $19.00 and gave the company a "neutral" rating in a report on Wednesday, May 13th. Scotiabank boosted their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a "sector perform" rating in a report on Wednesday. Finally, Weiss Ratings raised shares of Healthpeak Properties from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, May 8th. Five equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat.com, Healthpeak Properties has a consensus rating of "Hold" and an average price target of $19.23.
Read Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Featured Articles
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report